Fred Parietti: Co-founder and CEO of Multiply Labs

Robotic limbs at MIT

Parietti, who is Italian, earned a PhD in mechanical engineering at MIT in 2016. There he worked on supernumerary robotic limbs, wearable robot arms meant to help people with work, balance, and rehabilitation.^1,2

He met pharmaceutical scientist Alice Melocchi at MIT in 2014, and the two spent about three years on ideas at the meeting point of robotics and drugs before starting a company.¹

Building Multiply Labs

Parietti, Melocchi, Joe Wilson, and Tiffany Kuo started Multiply Labs in 2016 and joined Y Combinator, first building robots that 3D printed personalized supplement capsules.¹ The company later turned to cell therapy manufacturing, where Parietti has said most work is still done by hand in cleanrooms.³

On October 6, 2026, Multiply Labs raised a $75 million Series B led by Dr. Patrick Soon-Shiong with NantWorks, with AstraZeneca and Teradyne among the new investors, taking its total to over $100 million.⁴

Robotics is the only way to deliver these therapies to patients at scale. AI is designing more therapies than the industry will ever be able to manufacture.Multiply Labs Series B announcement

Sources

Photo: Multiply Labs, Team.